Myriad Genetics Inc. is suing two privately-held competitors to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Click here to read more in BloombergBusinessweek.
The Phillips DNA Project News
Myriad sues competitors over cancer gene test
- Details
- Category: Latest
- Written by Nancy Kiser